SCHEMBL25907342

SCHEMBL25907342

CC(C)(C)OC(=O)N1CC[C@H](NC(=O)OCc2ccccc2)[C@H]1CCO

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
CTSK P43235 2/20 0.44
CPB1 P15086 2/20 0.44
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
TSHR P16473 1/20 0.43
PDE4B Q07343 1/20 0.42
KLK7 P49862 1/20 0.42
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HSD11B1 P28845 1/20 0.41
ABCB1 P08183 1/20 0.41
DPP4 P27487 1/20 0.41
KCNH2 Q12809 1/20 0.41
DPP7 Q9UHL4 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
ACHE P22303 1/20 0.41
EPHX1 P07099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25907337 0.93 ALDH1A1 (0.47) ALDH1A1GAACTSKCPB1CTSL
SCHEMBL17228509 0.90 ALDH1A1 (0.43) ALDH1A1GAACTSKCPB1CTSL
SCHEMBL26782867 0.87 ALDH1A1 (0.44) ALDH1A1GAACTSKCPB1CTSL
SCHEMBL12836624 0.86 ELANE (0.47) ALDH1A1GAACTSKCPB1CTSL
SCHEMBL25907341 0.86 CTSK (0.50) ALDH1A1GAACTSKCPB1CTSL
SCHEMBL12836627 0.86 ELANE (0.47) ALDH1A1GAACTSKCPB1CTSL
SCHEMBL25320570 0.86 ALDH1A1 (0.48) ALDH1A1GAACTSKCPB1CTSL
SCHEMBL31321288 0.85 CPB1 (0.47) ALDH1A1GAACTSKCPB1CTSL
SCHEMBL14468657 0.85 ALDH1A1 (0.47) ALDH1A1GAACTSKCPB1CTSL
SCHEMBL4040280 0.85 ALDH1A1 (0.47) ALDH1A1GAACTSKCPB1CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12459922-B2 PARP7 inhibitors GILEAD SCIENCES, INC. (US) 2025-11-04 US disclosed
EP-4469448-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. (US) 2024-12-04 EP disclosed
CN-118591537-A PARP7 inhibitors 吉利德科学公司 2024-09-03 CN disclosed
US-20230365529-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. 2023-11-16 US disclosed
US-20230365529-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. 2023-11-16 US disclosed
WO-2023147418-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. (US) 2023-08-03 WO disclosed
WO-2023147418-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. (US) 2023-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12459922-B2 PARP7 inhibitors PARP1, PARP11, PARP2 ALDH1A1 1171/4885GAA 3475/4885CTSK 2511/4885
US-20230365529-A1 PARP7 INHIBITORS PARP1, PARP11, PARP2 ALDH1A1 1171/4885GAA 3475/4885CTSK 2511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.